Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled phase II dose-ranging study

Kim A. Papp; R. G. Langley; B. Sigurgeirsson; M. Abe; D. R. Baker; P. Konno; S. Haemmerle; H. J. Thurston; C. Papavassilis; H. B. Richards

doi:10.1111/bjd.12110

Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled phase II dose-ranging study

Kim A. Papp, R. G. Langley, B. Sigurgeirsson, M. Abe, D. R. Baker, P. Konno, S. Haemmerle, H. J. Thurston, C. Papavassilis, H. B. Richards

Inernational Relations Division

科研成果: 期刊稿件 › 文章 › 同行评审

327 引用（Scopus）

源语言	英语
页（从-至）	412-421
页数	10
期刊	British Journal of Dermatology
卷	168
期	2
DOI	https://doi.org/10.1111/bjd.12110
出版状态	已出版 - 2月 2013

!!!ASJC Scopus Subject Areas

皮肤医学

访问文件

10.1111/bjd.12110

其它文件与链接

引用此

Papp, K. A., Langley, R. G., Sigurgeirsson, B., Abe, M., Baker, D. R., Konno, P., Haemmerle, S., Thurston, H. J., Papavassilis, C., & Richards, H. B. (2013). Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled phase II dose-ranging study. British Journal of Dermatology, 168(2), 412-421. https://doi.org/10.1111/bjd.12110

Papp, KA, Langley, RG, Sigurgeirsson, B, Abe, M, Baker, DR, Konno, P, Haemmerle, S, Thurston, HJ, Papavassilis, C & Richards, HB 2013, 'Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled phase II dose-ranging study', British Journal of Dermatology, 卷 168, 号码 2, 页码 412-421. https://doi.org/10.1111/bjd.12110

@article{d5256f21becd4bd089eb0b76b995e4d4,

title = "Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled phase II dose-ranging study",

author = "Papp, {Kim A.} and Langley, {R. G.} and B. Sigurgeirsson and M. Abe and Baker, {D. R.} and P. Konno and S. Haemmerle and Thurston, {H. J.} and C. Papavassilis and Richards, {H. B.}",

year = "2013",

month = feb,

doi = "10.1111/bjd.12110",

language = "English",

volume = "168",

pages = "412--421",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis

T2 - A randomized, double-blind, placebo-controlled phase II dose-ranging study

AU - Papp, Kim A.

AU - Langley, R. G.

AU - Sigurgeirsson, B.

AU - Abe, M.

AU - Baker, D. R.

AU - Konno, P.

AU - Haemmerle, S.

AU - Thurston, H. J.

AU - Papavassilis, C.

AU - Richards, H. B.

PY - 2013/2

Y1 - 2013/2

UR - http://www.scopus.com/inward/record.url?scp=84873124241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873124241&partnerID=8YFLogxK

U2 - 10.1111/bjd.12110

DO - 10.1111/bjd.12110

M3 - Article

C2 - 23106107

AN - SCOPUS:84873124241

SN - 0007-0963

VL - 168

SP - 412

EP - 421

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 2

ER -

Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: A randomized, double-blind, placebo-controlled phase II dose-ranging study

!!!ASJC Scopus Subject Areas

访问文件

其它文件与链接

指纹

引用此